314 related articles for article (PubMed ID: 1714957)
21. In vitro activity profiles of cyclic and linear enkephalin pseudopeptide analogs.
Edwards JV; Spatola AF; Lemieux C; Schiller PW
Biochem Biophys Res Commun; 1986 Apr; 136(2):730-6. PubMed ID: 3010995
[TBL] [Abstract][Full Text] [Related]
22. Conformationally restricted deltorphin analogues.
Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of potent agonists of substance P by replacement of Met11 with Glu(OBzl) and N-terminal glutamine with Glp of the C-terminal hexapeptide and heptapeptide of substance P.
Stavropoulos G; Karagiannis K; Anagnostides S; Ministrouski I; Selinger Z; Chorev M
Int J Pept Protein Res; 1995 Jun; 45(6):508-13. PubMed ID: 7558580
[TBL] [Abstract][Full Text] [Related]
24. Metabolically stable analogues of substance P: persistent action of partially modified retro-inverso analogues of substance P on rat parotid and hypothalamic slices.
Chorev M; Rubini E; Hart Y; Gilon C; Wormser U; Selinger Z
Eur J Pharmacol; 1986 Aug; 127(3):187-95. PubMed ID: 2428641
[TBL] [Abstract][Full Text] [Related]
25. [Leu5]enkephalin containing peptides derived from a common precursor: evaluation of opioid activity in in vitro bioassays.
Sanchez-Blazquez P; Garzon J; Lee NM
Eur J Pharmacol; 1984 Mar; 98(3-4):389-96. PubMed ID: 6327333
[TBL] [Abstract][Full Text] [Related]
26. Effects of structurally different (Leu5) enkephalinamides on electrically-evoked contractions of guinea pig ileum.
Radomirov R; Petkov VD; Venkova K
Biomed Biochim Acta; 1987; 46(5):381-5. PubMed ID: 2822036
[TBL] [Abstract][Full Text] [Related]
27. Importance of the leucine side-chain to the spasmogenic activity and binding of substance P analogues.
Lavielle S; Chassaing G; Brunissen A; Rodriguez M; Martinez J; Convert O; Carruette A; Garret C; Petitet F; Saffroy M
Int J Pept Protein Res; 1993 Sep; 42(3):270-7. PubMed ID: 7693605
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological activity of substance P analogues.
Haro I; Torres JL; Valencia G; García-Antón JM; Reig F
Int J Pept Protein Res; 1989 May; 33(5):335-9. PubMed ID: 2475448
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
[TBL] [Abstract][Full Text] [Related]
30. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
Schiller PW; Nguyen TM; Lemieux C; Maziak LA
J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
[TBL] [Abstract][Full Text] [Related]
32. Topographically designed analogues of [D-Pen,D-Pen5]enkephalin.
Hruby VJ; Toth G; Gehrig CA; Kao LF; Knapp R; Lui GK; Yamamura HI; Kramer TH; Davis P; Burks TF
J Med Chem; 1991 Jun; 34(6):1823-30. PubMed ID: 1648137
[TBL] [Abstract][Full Text] [Related]
33. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.
James MK; Feldman PL; Schuster SV; Bilotta JM; Brackeen MF; Leighton HJ
J Pharmacol Exp Ther; 1991 Nov; 259(2):712-8. PubMed ID: 1658308
[TBL] [Abstract][Full Text] [Related]
34. Binding selectivity of short [D-Arg2,Leu5]enkephalin analogues to mu- and delta-subclasses of opiate receptors.
Rosenthal GF; Inkina NM; Abissova NA; Bobrova IV; Chipens GI
Biomed Sci; 1990 Apr; 1(4):414-6. PubMed ID: 1966782
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and opioid activities of [D-Leu-8]Dynorphin(1-8) analogs containing a reduced peptide bond, psi(CH2-NH).
Ambo A; Adachi T; Sasaki Y
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1547-50. PubMed ID: 7586080
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence.
Schmidt R; Kálmán A; Chung NN; Lemieux C; Horváth C; Schiller PW
Int J Pept Protein Res; 1995 Jul; 46(1):47-55. PubMed ID: 7558596
[TBL] [Abstract][Full Text] [Related]
37. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity and selectivity of glucosidic SP(6-11) analogues.
Haro I; Ruiz P; Valencia G; García-Antón JM; Reig F; Rodriguez RE
Pharmacol Biochem Behav; 1989 Nov; 34(3):527-32. PubMed ID: 2482980
[TBL] [Abstract][Full Text] [Related]
39. New reduced peptide bond substance P agonists and antagonists: effects on smooth muscle contraction.
Zacharia S; Rossowski WJ; Jiang NY; Hrbas P; Ertan A; Coy DH
Eur J Pharmacol; 1991 Oct; 203(3):353-7. PubMed ID: 1723044
[TBL] [Abstract][Full Text] [Related]
40. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
Cohen ML; Shuman RT; Osborne JJ; Gesellchen PD
J Pharmacol Exp Ther; 1986 Sep; 238(3):769-72. PubMed ID: 2875170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
